Using Evolutionary Models to Improve Cancer Treatment Strategies
Author Information
Author(s): Dabi Amjad, Brown Joel S., Gatenby Robert A., Jones Corbin D., Schrider Daniel R.
Primary Institution: University of North Carolina, Chapel Hill
Hypothesis
How do factors like the mutation rate and the rate at which a therapy kills cancer cells influence the probability that a two-strike treatment will achieve extinction?
Conclusion
The timing of switching to the second treatment significantly affects the likelihood of driving cancer to extinction, and extinction therapy is more effective than combination therapy when cross-resistance is present.
Supporting Evidence
- The study shows that the optimal timing of the second treatment can significantly increase the chances of cancer extinction.
- Combination therapy is generally more effective than sequential therapy unless cross-resistance mutations are present.
- Using a more effective drug first in a two-strike therapy leads to better outcomes.
Takeaway
This study looks at how to make cancer treatments better by using two different drugs in a specific order to kill cancer cells more effectively.
Methodology
Population genetic simulations were used to model the effects of sequential drug treatments on cancer cell populations.
Limitations
The simulations were conducted on a smaller population size than typically found in clinical settings, which may affect the generalizability of the results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website